about
DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast CancerMolecular analysis of thymoma.Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.Protein kinase C-beta as a therapeutic target in breast cancer.Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell linesUpregulation of HSF1 in estrogen receptor positive breast cancer.Molecular profiling assays in breast cancer: are we ready for prime time?NUT midline carcinomas in the thymic region.Role of lncRNAs in health and disease-size and shape matter.The prognostic value of architectural patterns in a study of 37 type AB thymomas.Tumor Heterogeneity in Breast Cancer.Micronodular thymic neoplasms: case series and literature review with emphasis on the spectrum of differentiation.A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells.beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer.Inhibition by NMDA of carbachol-stimulated inositol tetrakisphosphate accumulation in rat brain cortical slices.Redefining the target again: chemotherapeutics as vascular disrupting agents?Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancerSplicing factor controls ER-positive breast cancer by altering metabolic pathwaysNUT Midline Carcinoma Masquerading As a Thymic CarcinomaEnhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadateInsulin sensitizes beta-agonist and forskolin-stimulated lipolysis to inhibition by 2',5'-dideoxyadenosineWortmannin converts insulin but not oxytocin from an antilipolytic to a lipolytic agent in the presence of forskolinTumor marker assessment: points to ponderMultiplexed protein analysisFOXP3 expression and nodal metastasis of breast cancerBreast cancer prognostic markers: an overview of a changing menu
P50
Q33815545-A6ABD1E5-16EE-4AE6-AD0E-081B41306CB1Q34080323-68217227-0B91-4E90-A120-72DA9C77DF1DQ34388819-BC689D56-B937-4F33-9683-8782383600F8Q35148813-FDEADEE5-1E4E-4792-9247-353C5AEE0CF5Q35159916-DCA969F6-3F74-4AF6-A240-B4F7CAB35FFBQ36517267-BE98D8E7-2207-417A-8BA3-BEBE3E4CDB1BQ37103526-A7DFBDCD-9171-40D2-863C-CA265C4FBAA1Q37708937-76046701-DAD3-4335-8C33-BA404B099CC0Q38015422-D31B3162-AF1C-41DA-86EB-2C8B4DA4F056Q38213782-F13ED21E-0A5A-4E19-9849-72EFD8CC1A18Q38248414-DC8C4047-7BE9-43BC-8FB7-1EF03F949146Q38394224-6251073B-20EA-4051-A105-9B6E50E186FCQ38564373-491F5EA6-11C5-4193-8469-3D6E9A6AD3C2Q38584887-F291D4C3-12B9-4DE8-A86F-86FBFB7CA06CQ40255920-85D1EBC9-7671-41A4-AFBB-D010E3C714D6Q40360921-08F8D58E-563C-449B-AAC4-C53AB06F0C27Q44480778-E24FCE02-3512-4D94-9940-B17CDCC8B628Q46189717-7FFE5060-3609-4EB6-8958-45420A30EE90Q49022884-7A81C7CD-7FD0-4E3C-AF67-0C08E3B816B3Q52589053-E48921F0-C8EC-4149-9157-4CF95CF69C0EQ57049645-1F7D2432-B4BA-406E-8503-746205D4C32CQ62788210-F489C2BA-E5E6-43AE-9B03-63C2AF742BD3Q63658856-F48413CE-B5D2-4167-A8E4-58FD1D05125EQ71123447-B6F2FABB-9C11-41E7-9D2B-5E7E8EB0D08EQ71464161-565E6A24-4440-4138-B508-48AC57AB9DBBQ73006810-105454C3-40F7-4881-8A2F-99BB02BA83BAQ82997290-273A9833-43D0-4FD2-B697-1B9DF6D81B63Q87108768-3F36938A-6D7D-48DE-B9B2-44A280F112B3Q87345199-8CB7A5A2-BDD2-4500-80D3-06C1EB82FE93Q95492074-10689DAC-CF65-4D15-AAB1-3B98BFD92617
P50
description
researcher
@en
name
Gokmen-Polar Y
@nl
Yesim Gokmen-Polar
@en
type
label
Gokmen-Polar Y
@nl
Yesim Gokmen-Polar
@en
altLabel
Gokmen-Polar Y
@en
prefLabel
Gokmen-Polar Y
@nl
Yesim Gokmen-Polar
@en
P106
P31
P496
0000-0001-9927-4893